TIMBER PHARMACEUTICALS INC (TMBR)
US8870802084 - Common Stock
Timber Pharmaceuticals suspended from trading on NYSE American (NYSE:TMBR)
Timber Pharmaceuticals (TMBR) announces immediate suspension of common stock trading on NYSE America, expected to continue trading on OTC Market as TMBRQ.
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. (
Timber Pharmaceuticals Receives Court Approval of All First Day Motions to Support Business Operations & Discloses Communication From NYSE American
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical...
Timber Pharmaceuticals files for Chapter 11 in wake of failed merger (NYSE:TMBR)
Timber Pharmaceuticals (TMBR) reportedly filed for Chapter 11 bankruptcy protection Friday afternoon after shareholders again refused to approve a planned merge
Timber Pharma stock down ahead of shareholder vote on merger
Timber Pharmaceuticals (TMBR) shares fall ahead of a crucial shareholder meeting on Friday regarding its proposed merger with LEO Pharma. Read more here.
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, ESTE, PR, TMBR
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders
Timber to be taken private by LEO Pharma, stock soars 100% (NYSE:TMBR)
Timber Pharmaceuticals (TMBR) shares soared 100% Monday after the biotech company said it had agreed to be taken private by Danish dermatology company LEO Pharma. Read more here.
Timber Pharmaceuticals to be acquired by Denmark-based LEO Pharma (NYSE:TMBR)
Biopharmaceutical company Timber Pharmaceuticals (TMBR) Monday entered into a definitive agreement to be acquired by Danish pharmaceutical company LEO Pharma.The transaction was valued...
Why Is Skillz (SKLZ) Stock Up 20% Today?
Skillz (SKLZ) stock is taking off on Monday after the mobile gaming company announced plans for a share repurchase program.
Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?
Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal.
Timber Pharmaceuticals to be Acquired by LEO Pharma
Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up...
Timber Pharmaceuticals to be Acquired by LEO Pharma
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Timber Pharmaceuticals receives NYSE notice on non-compliance (NYSE:TMBR)
Biopharmaceutical company Timber Pharmaceuticals (TMBR) said on Monday that it had received NYSE American notice on non-compliance with the stock exchange's rules related to...
Timber Pharmaceuticals Discloses Communication From NYSE American
WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a...
Timber Pharmaceuticals Discloses Communication From NYSE American
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Timber Pharmaceuticals gets FDA waiver to forgo rodent study (NYSE:TMBR)
Shares of micro-cap Timber Pharmaceuticals (TMBR) soared as much as 83% on Monday after the company was granted a FDA waiver to forgo a rodent study for TMB-001.
Stocks: AAPL rises all time-high; TGT falls on downgrade; PANW, TMBR gain; EPAM, BLPH down
During Monday's intraday session, major market indexes traded mixed as investors tried to assess the likelihood of the Fed hiking interest rates again next week.Looking at the...
AAPL rises to all time high; TGT falls on downgrade; PANW, TMBR gain; EPAM, BLPH slip
During Monday's intraday session, major market indexes traded mixed as investors tried to assess the likelihood of the Fed hiking interest rates again next week.Looking at the...